Terns Pharmaceuticals Inc (TERN)
6.14
+0.15
(+2.50%)
USD |
NASDAQ |
May 16, 16:00
6.145
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Operations (Quarterly): -22.80M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -22.80M |
December 31, 2023 | -19.32M |
September 30, 2023 | -20.70M |
June 30, 2023 | -12.99M |
March 31, 2023 | -14.38M |
December 31, 2022 | -11.21M |
September 30, 2022 | -13.44M |
June 30, 2022 | -11.16M |
March 31, 2022 | -13.30M |
Date | Value |
---|---|
December 31, 2021 | -10.67M |
September 30, 2021 | -8.082M |
June 30, 2021 | -8.76M |
March 31, 2021 | -14.32M |
December 31, 2020 | -7.387M |
September 30, 2020 | -6.313M |
June 30, 2020 | -8.822M |
March 31, 2020 | -7.287M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-22.80M
Minimum
Mar 2024
-6.313M
Maximum
Sep 2020
-12.41M
Average
-11.21M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
Viking Therapeutics Inc | -6.134M |
Eli Lilly and Co | 1.166B |
Pfizer Inc | 1.09B |
Amgen Inc | 689.00M |
Madrigal Pharmaceuticals Inc | -149.16M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 7.997M |
Free Cash Flow | -75.89M |
Free Cash Flow Per Share (Quarterly) | -0.3068 |
Free Cash Flow Yield | -17.07% |